ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,608.25
      0.97%
      US Tech 100
      19,254.80
      1.33%
      Dow Jones
      40,896.53
      0.58%
      Brent Oil
      77.29
      -0.11%
      Bitcoin
      60,559.91
      1.83%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. USOTC

      6. Medios AG (PK) (MEDOF) Quote

      Medios AG (PK)

      Medios AG (PK) (MEDOF)

      USOTC
      13.64
      0.00
      (0.00%)
      Closed August 19 4:00PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      13.64
      Bid
      0.0004
      Ask
      380.86
      Volume
      -
      0.00 Day's Range 0.00
      13.64 52 Week Range 13.64
      Market Cap
      324.71M
      Previous Close
      13.64
      Open
      -
      Last Trade
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      23,805,723
      Dividend Yield
      -
      PE Ratio
      0.00
      Earnings Per Share (EPS)
      -
      Revenue
      1.79B
      Net Profit
      18.81M

      About Medios AG (PK)

      Sector
      Radio, Tv Broadcast, Comm Eq
      Industry
      Radio, Tv Broadcast, Comm Eq
      Website
      www.medios.ag
      Headquarters
      Berlin, Deu
      Founded
      1970
      Medios AG (PK) is listed in the Radio, Tv Broadcast, Comm Eq sector of the OTCMarkets with ticker MEDOF. The last closing price for Medios (PK) was $13.64. Over the last year, Medios (PK) shares have traded in a share price range of $ 13.64 to $ 13.64.

      Medios (PK) currently has 23,805,723 shares outstanding. The market capitalization of Medios (PK) is $324.71 million.

      MEDOF Latest News

      More News

      Merck to Acquire Investigational B-Cell Depletion Therapy, CN201, from Curon Biopharmaceutical

      CN201 is a next generation CD3xCD19 bispecific antibody that augments and diversifies Merck’s pipeline, with potential applications in B-cell malignancies and autoimmune diseases Merck (NYSE:...

      August 09 2024
      Business Wire

      Merck Provides Update on Phase 3 KeyVibe-008 Trial Evaluating an Investigational Fixed-Dose Combination of Vibostolimab and Pembrolizumab in Patients With Extensive-Stage Small Cell Lung Cancer

      Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the discontinuation of the Phase 3 KeyVibe-008 trial based on the recommendation of an independent Data...

      August 08 2024
      Business Wire

      Form 4 - Statement of changes in beneficial ownership of securities

      August 06 2024
      Edgar (US Regulatory)

      Daiichi Sankyo and Merck Enter into Global Development and Commercialization Agreement for MK-6070

      Agreement builds on and complements Daiichi Sankyo and Merck’s shared commitment to develop novel medicines for patients with cancer Daiichi Sankyo and Merck to co-develop and co-commercialize...

      August 06 2024
      Business Wire

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      August 05 2024
      Edgar (US Regulatory)

      IDeate-Lung02 Phase 3 Trial of Ifinatamab Deruxtecan Initiated in Patients with Relapsed Small Cell Lung Cancer

      Daiichi Sankyo (TSE: 4568) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the first patient has been dosed in the IDeate-Lung02 phase 3 trial...

      August 01 2024
      Business Wire

      Form 8-K - Current report

      July 30 2024
      Edgar (US Regulatory)

      Merck Announces Second-Quarter 2024 Financial Results

      Total Worldwide Sales Were $16.1 Billion, an Increase of 7% From Second Quarter 2023; Excluding the Impact of Foreign Exchange, Growth Was 11% KEYTRUDA Sales Grew 16% to $7.3 Billion; Excluding...

      July 30 2024
      Business Wire

      Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as First-Line Treatment for Patients With Unresectable or Metastatic Urothelial Carcinoma

      Opinion granted based on positive overall survival and progression-free survival results from the Phase 3 KEYNOTE-A39 trial Positive opinion marks step forward for a potential new first-line...

      July 26 2024
      Business Wire

      Merck Announces Fourth-Quarter 2024 Dividend

      Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Board of Directors has declared a quarterly dividend of $0.77 per share of the company’s common...

      July 23 2024
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      260013.6413.6413.64200013.64CS
      520013.6413.6413.64200013.64CS
      156-36.36-72.72505013.64107516.17674419CS
      260-28.3179-67.491223345341.95795013.6487527.20801143CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ELYSElys BMG Group Inc (CE)
      $ 0.0021
      (209,900.00%)
      		12.08k
      WTERAlkaline Water Company Inc (CE)
      $ 0.001
      (99,900.00%)
      		44.78k
      MOTNFPowertap Hydrogen Capital Corporation (CE)
      $ 0.07
      (69,900.00%)
      		6.75k
      GDMIFGreen Mining Innovation Inc (PK)
      $ 0.201
      (28,614.29%)
      		100
      TRLFFMaven Brands Inc (CE)
      $ 0.013
      (12,900.00%)
      		580
      FTDLFirsTime Design Limited (CE)
      $ 0.000001
      (-99.89%)
      		1.58k
      ASKEAlaska Pacific Energy Corporation (CE)
      $ 0.000001
      (-99.80%)
      		2.8M
      SPRNSupernova Energy Inc (CE)
      $ 0.000001
      (-99.50%)
      		28.82k
      NTRRNeutra Corporation (CE)
      $ 0.000001
      (-99.50%)
      		136
      MJWLMajic Wheels Corp (CE)
      $ 0.000001
      (-99.50%)
      		25.2k
      ABQQAB International Group Corporation (PK)
      $ 0.0009
      (12.50%)
      		174M
      GSTCGlobestar Therapeutics Corporation (PK)
      $ 0.0005
      (-28.57%)
      		149.54M
      AAPJAAP Inc (PK)
      $ 0.0001
      (0.00%)
      		140.19M
      ASIIAccredited Solutions Inc (PK)
      $ 0.00135
      (-10.00%)
      		135.88M
      ICBUIMD Companies Inc (PK)
      $ 0.0018
      (5.88%)
      		134.86M

      Discussion

      View Full Feed
      surfkast surfkast 5 minutes ago
      That information is spot on for the DD Support Board and Research Team. Just facts!
      m$teamworkotc m$teamworkotc 5 minutes ago
      shut this and igpk scams down. disgorge the crooks
      SPZI
      3331 3331 6 minutes ago
      Will BIEL run over .01? It's possible with management support. Hope they realize an increasing pps and market cap can be just as important as a huge contract (if not more so). Great management would capitalize on this opportunity.
      BIEL
      hedge_fun hedge_fun 6 minutes ago
      SFRX posted about artifacts earlier on YouTube……..

      These are something special, no doubt, but I still prefer those $10K plus trinkets.

      https://investorshub.advfn.com/uimage/uploads/2024/8/19/xftneIMG_0252.jpeg
      SFRX
      privatee privatee 7 minutes ago
      Come up for air dude!
      GDVM
      tdbowieknife tdbowieknife 7 minutes ago
      The good news is.... FINRA will not process an R/S, or any other corporate action. George could make the best of it and get one of his sleazy scammers to use this to pump and dump some stock.


      ..


      Buyer Beware
      Pump and dump
      http://image
      GVSI
      Bountiful_Harvest Bountiful_Harvest 7 minutes ago
      I think this record "melt-up" rally will be followed by a record crash very soon. Once NVDA bubble pops, that's it for the AI bubble. All this rally did was set things up for a harder crash.

      I picked up some NVD shares right after the close.
      NVD NVDA
      zab zab 7 minutes ago
      DJT $22.39, talk about eating your own, the stock market keeps climbing, and trumps stock is just like his campaign, keeps going down. Not many will be around much longer, including yourself, the stock will be gone, trump will be gone, and you will fade away, now that's eating your own.
      DJT
      2018trader 2018trader 8 minutes ago
      Yep extreme circumstances call for extreme measures
      SPY
      surfkast surfkast 8 minutes ago
      Maybe, but since he grew his stable from 14 to over 100 horses since playing the shell game, my money is on the following.....

      https://pbs.twimg.com/media/A0ibn3GCcAEoMQp?format=jpg&name=medium
      GVSI
      delerious1 delerious1 8 minutes ago
      So this is how this board responds to questions....kinda sad to see comments from the board like:

      "The poster is looking to trip someone up "

      "he can run back to the board and say; SEEEEE janice said so"

      "The same poster and several others picked up nodum
      G Burnelli G Burnelli 8 minutes ago
      Predictions of NASH market size were also just that… predictions. MDGL’s Q2 earnings may have tempered expectations on how large the market actually is (given the rise of GLPs).

      Obesity market size on the other hand has just been growing (both LLY and NVO’s blockbuster results).
      LLY MDGL
      ron_66271 ron_66271 8 minutes ago
      TPS Is Class 19. So Class 19 Isn’t Being Paid?

      Your documents referenced don’t work.

      Please try again.

      I have proven how all Class 19 and Class 22 are to be paid from the February MOR Retained Earnings.
      75/25%.

      Thanks for proving me
      COOP
      HammerSown HammerSown 9 minutes ago
      What news do you think is coming?
      HITC
      Scarbender307 Scarbender307 9 minutes ago
      Thanks "D" ..Looks like they acquired their 1/3rd ownership at .72 cents per share. Hope it makes sense.
      AOIFF
      moe_the_gyp01 moe_the_gyp01 9 minutes ago
      Yeah, refute one item of it!
      RNVA
      Filterthenoise Filterthenoise 9 minutes ago
      Tik toK bichazz!
      RNVA
      burner67 burner67 9 minutes ago
      Jewels of the OTC lolol. You've been saying the same thing for ages. 'Soon' is your favorite word. You are most likely an FOJ and you have no credibility here.
      BEGI
      KevGee59 KevGee59 10 minutes ago
      LOL!
      No worries...thought it was funny!
      NWBO
      Nukemtiltheyglow Nukemtiltheyglow 11 minutes ago
      lizzy; nice beat down....
      AMRN
      Double DD Double DD 11 minutes ago
      And tom this could open at .oo6 too, just the opposite of today!! Heavy manipulation!! Igpk
      IGPK
      zooey zooey 12 minutes ago
      He, and a family member were buyers, but he will never admit it..
      APRU
      Billyjack68 Billyjack68 12 minutes ago
      Thank you Richie, certainly agree and appreciate the wisdom. Patrick is no slouch and carries a high degree of respect in this business space. One only needs to look at his numerous advisory roles and boards which he obviously enjoys committed roles and allies across the field. 100% confident in
      AFFU

      Your Recent History

      USOTC
      MEDOF
      Medios (PK)
      BIT
      UC45ZC
      Unicredit Bank
      Delayed Upgrade Clock